Stocks Move Lower After Back-to-Back Winning Weeks
Stock futures traded lower Monday as markets cooled off following a winning week on hopes for rate cuts from the Federal Reserve.
Futures for the Dow Jones Industrials backed up 36 points, or 0.1%, to 45,004.
Futures for the S&P 500 lost 7.25 points, or 0.1%, to 6,464.25
Futures for the NASDAQ slid 38.5 points, or 0.2%, to 23,766.
Tesla shares dipped about 0.7% after The Times of London reported that the electric car maker is now offering discounts of up to 40% on leased vehicles in the country as sales slump.
The Fed will continue to be in focus this week as central bank members travel to Jackson Hole, Wyoming, for the annual economic policy symposium. Investors will be monitoring the event for clues about the future path of rates. Fed funds futures are pricing in a nearly 85% likelihood that the central bank cuts rates at its next policy meeting in September.
Beyond economic policy, traders will be monitoring earnings reports due over the course of the week as the season winds down. Big-box retailers, including Home Depot, Lowe’s, Walmart and Target, are among the major companies slated to release results this week.
Of the more than 92% of S&P 500 companies that have already reported this quarter, almost 82% have reportedly surpassed Wall Street’s expectations.
In Japan, the Nikkei 225 surged 0.8% Monday, while in Hong Kong, the Hang Seng ducked 0.4%.
Oil prices poked ahead 30 cents to $63.10 U.S. a barrel.
Gold prices vaulted $11.80 at $3,394.20 U.S. per ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


